Boška Hrvačić

Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2- <i>a</i> ]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fibrosis

Nicolas Desroy, Christopher Housseman, Xavier Bock et al. · Journal of Medicinal Chemistry · 2017 · 139 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +8

Anti-inflammatory activity of azithromycin attenuates the effects of lipopolysaccharide administration in mice

Vanesa Ivetić Tkalčević, Berislav Bošnjak, Boška Hrvačić et al. · European Journal of Pharmacology · 2006 · 88 citations

Medicine, Immunology, Pharmacology +14

Azithromycin and Clarithromycin Inhibit Lipopolysaccharide-Induced Murine Pulmonary Neutrophilia Mainly through Effects on Macrophage-Derived Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-1β

Martina Bosnar, Berislav Bošnjak, Snježana Čužić et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 88 citations

Medicine, Immunology, Pharmacology +17

Azithromycin inhibits macrophage interleukin-1β production through inhibition of activator protein-1 in lipopolysaccharide-induced murine pulmonary neutrophilia

Martina Bosnar, Snježana Čužić, Berislav Bošnjak et al. · International Immunopharmacology · 2010 · 63 citations

Life Sciences, Immunology, Pharmacology +16

Claudins: Beyond Tight Junctions in Human IBD and Murine Models

Snježana Čužić, Maja Antolić, Anja Ognjenović et al. · Frontiers in Pharmacology · 2021 · 45 citations · Full text

Life Sciences, Cell Biology, Immunology +17